Gates Foundation Invests in Pharma: Conflict of Interest?

In March of this year, the Bill & Melinda Gates Foundation invested $10 million in Liquidia Technologies, a biotechnology company focused on vaccine development. According to Jeff Raikes, the CEO of the Gates Foundation, this is a way to “tap into the private sector … [to] add to the work we are doing and leverage … Continue reading

The Gates Foundation: Hand In Hand With Pharma

Some weeks ago, we posted here on the problem with medical studies, as explained by Dr. John Ioannidis, a worldwide authority on the subject. One of the issues he pointed out was that of conflicts of interest that occur when the pharmaceutical industry itself commissions or conducts research on its own safety. So how much … Continue reading